Merck KGaA isn't interested in a big deal; India caps more drug prices; Rottapharm IPO scrapped;

@FiercePharma: Top-read on FP this weekend: Sun issues third recall since announcing deal to buy Ranbaxy. Article | Follow @FiercePharma

@TracyStaton: ICYMI: MannKind says it won't launch Afrezza without a partner. We updated our story. | Follow @TracyStaton

@EricPFierce: ICYMI last week: Weak link in the supply chain. Pharmacist walks out of NY hospital with 1,500 oxycodone tabs. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI: Solid PhIII brings Sanofi closer to blockbuster dengue sales. FierceVaccines story | Follow @CarlyHFierce

> Merck KGaA's pharma chief, Stefan Oschmann, says he's not looking for a merger of equals, but is shopping for mid-sized acquisitions. Report

> India has capped prices on more than 100 drugs in a move likely to slash profit margins at local units of multinational drugmakers, including Sanofi ($SNY) and Abbott Laboratories ($ABT). Report

> Nestlé's new dermatology unit Galderma amped up its partnership with the French drugmaker Ipsen, with plans to boost sales of a Botox competitior. Report

> Italy's Rovati family can't catch a break: After failing to sell Rottapharm, the family proposed an IPO, but investors wouldn't bite. Report

Medical Device News

@FierceMedDev: Massachusetts med tech outfit wins $1M from NIH to develop pediatric stent system. Story | Follow @FierceMedDev

@StacyALawrence: ICYMI last week: FDA clears oral sleep apnea device, as search for CPAP alternatives continues. Story | Follow @StacyALawrence

@VarunSaxena2: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go farther. Article | Follow @VarunSaxena2

@MichaelGFierce: MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. More | Follow @MichaelGFierce

@EmilyWFierce: Global infectious diseases are infiltrating the Times' crossword puzzles. Here's a roundup of clues: More | Follow @EmilyWFierce

> Virtual Finger provides faster, better way to study 3D images. Item

> Virtual reality headset and Google Glass team up in Spanish surgery. Report

Biotech News

@FierceBiotech: Fresh off Phase III success, Otonomy shoots for an $86M IPO. Story | Follow @FierceBiotech

@JohnCFierce: I'm soon going offline for a week. will be holding down the fort. Please postpone all big news until I get back. :) | Follow @JohnCFierce

@DamianFierce: Via @WSJ, $ABBV + $SHPG would leapfrog $LLY. More | Follow @DamianFierce

@EmilyMFierce: Like in Humans, Genes Drive Half of Chimp Intelligence, Study Finds via . Article | Follow @EmilyMFierce

> Does crowdfunding work in biotech? Item

> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. More

> Roche and Exelixis herald a Phase III victory for their melanoma combo. News

CRO News

> China's HD Bio teams with Marshall U. for cancer R&D. Article

> CMOs eye Russia for growth. Item

> InVentiv joins a nonprofit effort to make trials more efficient. News

> Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO. Story

> U.K. CRO emerges from $100M in deals with plans for more M&A. Article

Biotech IT News

> Google creates new cash source for European biotech IT startups with $100M VC fund. News

> Row over IT focus of Europe's brain project prompts 280 scientists to threaten a boycott. Story

> PHT prioritizes Android over Apple in preparation for 'bring your own device' trials. Article

> FDA warns Gilead over 'misleading' paid search link. Item

> After working to mimic the brain for 9 years, Numenta reflects on limitations of today's hardware. Story

Animal Health News

> PEDv diagnostic hits market as vets predict 2.5 million more deaths. Story

> U.K. animal care company profits from generic pet meds. Article

> Industry Voices: How to win at animal health. Report

> Vets may soon be able to carry scheduled drugs. News

> Report: China animal vaccine market up by 26%. Story

And Finally... New York Gov. Andrew Cuomo is catching flak for his plans to use Gilead Sciences' ($GILD) Truvada to prevent the spread of HIV. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.